EVENTS & NEWS
ECIV is a coalition at the European Union and wider international level between IBVTA and FIVAPE. Through the provision of credible knowledge and guidance, ECIV supports the independent vape trade and promotes constructive interaction between this industry sector and the scientific community, vapers, policy makers, and the general public. ECIV fosters research and manufacturing excellence in order to deliver a proportionate consumer regulatory landscape that adequately reflects the needs of vaping stakeholders and recognises vaping as a sector in its own right.
Vaping is not a gateway to smoking and does not result in normalisation of smoking.
(Royal College of Physicians, April 2016)
Six million people successfully stopped smoking in Europe thanks to vape products.
The current best estimate is that vaping is at least 95% less harmful than smoking.
(Public Health England, August 2015 and Royal College of Physicians, April 2016)
In many Member States vaping is now recognised as the number one tool used by smokers to quit.
Vaping represents a market-based, user-driven public health insurgency. No public money has been spent, yet smokers are switching, and cutting down through using vape products.
99.9% of vapers are current or former smokers.
(Action on Smoking and Health and UK Office of National Statistics)
Vaping is 60% more effective than conventional NRT products in helping smokers quit.
(Professor Robert West, University College London)
ECIV will be organising an event in Brussels later this year. If you would like to get involved or find out more, please contact email@example.com
WHO COP7 Report - November 2016
SIGN UP TO OUR NEWSLETTER